Wanli Ma

1.1k total citations
51 papers, 845 citations indexed

About

Wanli Ma is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Wanli Ma has authored 51 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Epidemiology. Recurrent topics in Wanli Ma's work include Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Wanli Ma is often cited by papers focused on Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Wanli Ma collaborates with scholars based in China, United States and Australia. Wanli Ma's co-authors include Jiao Luo, Dianke Yu, Yuan Jin, Lin Xu, Chuanhai Li, Jie Chai, Hua Long, Jiangtao Chen, Kunhou Yao and Chenyu Wang and has published in prestigious journals such as Journal of Clinical Investigation, The Science of The Total Environment and Hepatology.

In The Last Decade

Wanli Ma

44 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanli Ma China 16 458 313 147 76 66 51 845
Jiao-Yang Li China 19 613 1.3× 404 1.3× 77 0.5× 91 1.2× 101 1.5× 53 1.1k
Haili Huang China 22 588 1.3× 308 1.0× 92 0.6× 83 1.1× 101 1.5× 47 1.0k
Kunming Zhao China 15 456 1.0× 267 0.9× 74 0.5× 53 0.7× 71 1.1× 34 712
Xinyue Deng China 16 478 1.0× 282 0.9× 79 0.5× 45 0.6× 110 1.7× 43 1.1k
Briana K. Shimada United States 11 331 0.7× 190 0.6× 231 1.6× 50 0.7× 38 0.6× 16 759
Hui Peng China 19 600 1.3× 415 1.3× 140 1.0× 88 1.2× 108 1.6× 50 1.2k
Yajing Zhang China 20 756 1.7× 408 1.3× 90 0.6× 58 0.8× 142 2.2× 56 1.1k
Lingxiang Yu China 16 397 0.9× 284 0.9× 84 0.6× 47 0.6× 92 1.4× 48 703

Countries citing papers authored by Wanli Ma

Since Specialization
Citations

This map shows the geographic impact of Wanli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanli Ma more than expected).

Fields of papers citing papers by Wanli Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanli Ma. The network helps show where Wanli Ma may publish in the future.

Co-authorship network of co-authors of Wanli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Wanli Ma. A scholar is included among the top collaborators of Wanli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanli Ma. Wanli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Wanli, Xinyi Liu, Ran Yu, et al.. (2025). Exploring the relationship between sepsis and Golgi apparatus dysfunction: bioinformatics insights and diagnostic marker discovery. Frontiers in Genetics. 16. 1483493–1483493.
2.
Luo, Xingqi, et al.. (2025). Becoming a Researcher: An Empirical Study on the Factors Influencing Chinese PhD Students’ Research Career Intentions. Behavioral Sciences. 15(2). 123–123. 1 indexed citations
3.
Li, Chunyu, Wanli Ma, Jingran Zhang, et al.. (2025). A novel non-invasive murine model for rapidly testing drug activity via inhalation administration against Mycobacterium tuberculosis. Frontiers in Pharmacology. 15. 1400436–1400436.
4.
Xu, Lin, Wanli Ma, Xiaoyu Huo, et al.. (2024). New insights into the function and mechanisms of piRNA PMLCPIR in promoting PM2.5-induced lung cancer. Journal of Advanced Research. 73. 659–670. 9 indexed citations
5.
Ma, Wanli, Chenghui Wang, Zhiqiang Chen, et al.. (2024). Catalytic hydrogenolysis of polypropylene and polyethylene mixtures: Effect of temperature on liquid alkane components. Journal of the Energy Institute. 115. 101615–101615. 7 indexed citations
6.
Jin, Yuan, Lin Xu, Ningning Chen, et al.. (2023). An entropy weight method to integrate big omics and mechanistically evaluate DILI. Hepatology. 79(6). 1264–1278. 9 indexed citations
7.
Xu, Lin, Yanting Li, Wanli Ma, et al.. (2023). Diesel exhaust particles exposure induces liver dysfunction: Exploring predictive potential of human circulating microRNAs signature relevant to liver injury risk. Journal of Hazardous Materials. 458. 132060–132060. 6 indexed citations
8.
Luo, Jiao, Ge Song, Ningning Chen, et al.. (2023). Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation. Cell Death Discovery. 9(1). 311–311. 39 indexed citations
10.
Xu, Lin, Wanli Ma, Yuan Jin, et al.. (2022). N, N-dimethylformamide exposure induced liver abnormal mitophagy by targeting miR-92a-1-5p-BNIP3L pathway in vivo and vitro. The Science of The Total Environment. 839. 156218–156218. 18 indexed citations
12.
Jin, Yuan, Daochuan Li, Yuzhen Liu, et al.. (2021). High throughput data-based, toxicity pathway-oriented development of a quantitative adverse outcome pathway network linking AHR activation to lung damages. Journal of Hazardous Materials. 425. 128041–128041. 49 indexed citations
13.
Luo, Jiao, Yufei Hou, Wanli Ma, et al.. (2021). A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells. Biochemical Pharmacology. 189. 114458–114458. 32 indexed citations
14.
Luo, Jiao, Yufei Hou, Wanli Ma, et al.. (2021). A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease. Biochemical Pharmacology. 188. 114582–114582. 15 indexed citations
15.
Xu, Lin, Qianwen Zhao, Jiao Luo, et al.. (2020). Integration of proteomics, lipidomics, and metabolomics reveals novel metabolic mechanisms underlying N, N-dimethylformamide induced hepatotoxicity. Ecotoxicology and Environmental Safety. 205. 111166–111166. 35 indexed citations
17.
Lin, Hua, Zhaohui Tong, Qianqian Xu, et al.. (2014). Interplay of Th1 and Th17 Cells in Murine Models of Malignant Pleural Effusion. American Journal of Respiratory and Critical Care Medicine. 189(6). 697–706. 55 indexed citations
18.
Ma, Wanli, et al.. (2014). Serum amyloid A promotes osteosarcoma invasion via upregulating αvβ3 integrin. Molecular Medicine Reports. 10(6). 3106–3112. 11 indexed citations
19.
Ma, Wanli, Weihong Han, Peter A. Greer, et al.. (2011). Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease. Journal of Clinical Investigation. 121(11). 4548–4566. 85 indexed citations
20.
Ma, Wanli, Yi-Fan Li, Dezhi Sun, Hong Qi, & Liyan Liu. (2010). Polycyclic aromatic hydrocarbons in air of Harbin City. China Environmental Science. 30(2). 145–149. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026